Voluntary Licensing: Optimizing Global Efforts And Measuring Impact, I-MAK/ITPC
For the past decade, pharmaceutical companies have increasingly used voluntary licenses to allow generic production of patented antiretroviral drugs for People Living with HIV/AIDS in poor countries. However, these licenses have not been pursued optimally from a public health standpoint. This paper will comment on the current efforts of global health institutions and propose a…
Evaluating The Potential Impact Of Aurobindo’s Unbundling
Examination of the potential benefit, if any, of Aurobindo’s decision to opt out of the MPP-Gilead license for TDF.
Financial Impact Of The Medicines Patent Pool: I-MAK/ITPC Counter Analysis
We prepared the following analysis as a response to claims made by the MPP about its economic benefits.
Briefing Paper: Analysis Of The Patent Pool Licenses
Intellectual Property, Technology Transfer And Manufacture Of Low-Cost HPV Vaccines In India, Swathi Padmanabhan, Tahir Amin, Bhaven Sampat, Robert Cook-Deegan and Subhashini Chandrasekharan, Nature Biotechnology
An empirical study of the impact of patenting and licensing on regional manufacturing of human papilloma virus vaccines to help improve vaccine affordability and access.
Voluntary Licensing Practices in the Pharmaceutical Sector: An Acceptable Solution to Improving Access to Affordable Medicines?
Tahir Amin, Oxfam
Partner with us now to build
a more just and equitable
medicine system for all.